SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is seeing intense community discussion and a significant price surge following the announcement of 2.8 billion dollars in new multi-year AI cloud contracts and an increased annualized revenue target. Investors are actively debating the company's transition from a bitcoin miner to a high-capacity AI infrastructure provider, with bulls highlighting the major customer roster and customer-funded expansion while bears remain skeptical about dilution and execution risks.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending as investors react to the launch of 'Thunder,' a jointly-developed autonomous VTOL platform with Anduril Industries targeting defense and commercial markets. While the community is actively debating the stock's long-term viability and the timeline for commercialization, the news has sparked significant retail interest and high trading volume, with supporters pointing to the company's substantial liquidity as a key buffer for ongoing development.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is experiencing significant downward pressure as investors navigate heavy selling volume following the recent TopBuild acquisition and concerns over share dilution. While some in the community are frustrated by the stock's stagnation and the CEO's lack of immediate public commentary, others view the current price as a long-term value opportunity and are actively debating the timing of a potential turnaround.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is experiencing significant volatility as market participants weigh potential government quantum infrastructure contracts against a broader sector-wide cooling of speculative growth stocks. While community sentiment remains polarized, ongoing discussions focus on the company's long-term commercialization roadmap, upcoming earnings expectations, and the strategic implications of its recent manufacturing-focused acquisition.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The VanEck Semiconductor ETF is experiencing intense volatility and profit-taking as investors grapple with record inflows, shifting institutional sentiment, and concerns regarding the sustainability of AI capital expenditure. While the broader uptrend remains a key talking point for the community, active debates continue over whether this pullback is a healthy consolidation or the start of a deeper sector-wide correction.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix Biopharma is trending following a STAT News report detailing that a former Chief Medical Officer was a fugitive living under an alias, leading to his termination. While the market reacted with volatility, investors are actively debating whether this is an overreaction, noting that the clinical pipeline and underlying science remain unaffected by the executive leadership controversy.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is drawing significant investor interest after NVIDIA disclosed a 9.3% passive stake in the company, a move that community members are interpreting as a powerful long-term endorsement of its AI cloud infrastructure. While some traders are focused on the potential for a short-term squeeze, many in the community are emphasizing the stock's long-term growth potential and are actively discussing the implications of institutional backing alongside recent analyst price target upgrades.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Semiconductor stocks are facing intense volatility and a sharp market sell-off as investors react to escalating geopolitical tensions, concerns over AI capital expenditure ROI, and a broader rotation out of crowded tech trades. The community is deeply divided, with many traders debating whether this historic washout is a temporary capitulation and a prime buying opportunity, or the beginning of a prolonged bear trend that could push prices significantly lower.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trending due to significant investor speculation regarding a potential bidding war, as an Israeli-led consortium has submitted a buyout offer at a premium to the previously agreed deal with Hapag-Lloyd. The community is actively discussing the impact of geopolitical tensions on freight rates, the potential for lucrative dividend payouts, and the regulatory challenges surrounding the Israeli government's 'golden share' approval process.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean (RIG) is currently trending as investors weigh strong operational fundamentals against market volatility tied to ongoing Middle East geopolitical tensions and energy sector uncertainty. While the company continues to secure lucrative long-term contracts and improve its balance sheet through debt reduction, community sentiment remains divided over the potential impact of its pending merger with Valaris and broader market manipulation concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Artiva Biotherapeutics, Inc. (ARTV) Outperforming Other Medical Stocks This Year?

Here is how Artiva Biotherapeutics, Inc. (ARTV) and Climb Bio, Inc. (CLYM) have performed compared to their sector so far this year.

Climb Bio (NASDAQ:CLYM) Reaches New 52-Week High Following Analyst Upgrade

Climb Bio (NASDAQ:CLYM) Reaches New 52-Week High Following Analyst Upgrade...

Climb Bio (NASDAQ:CLYM) Stock Price Expected to Rise, BTIG Research Analyst Says

BTIG Research boosted their price objective on shares of Climb Bio from $8.00 to $19.00 and gave the company a 'buy' rating in a report on Wednesday...

Climb Bio (NASDAQ:CLYM) Trading 10.8% Higher - What's Next?

Climb Bio (NASDAQ:CLYM) Trading 10.8% Higher - What's Next...

Climb Bio Spotlights Budoprutug CD19 Strategy, Sets Up 2026 Data Readouts in pMN, ITP and SLE

Climb Bio (NASDAQ:CLYM) used an investor R&D spotlight event to outline its strategy around CD19-targeted B-cell depletion and to provide updates on development plans and timelines for its lead...

Climb Bio, Inc. $CLYM Shares Sold by JPMorgan Chase & Co.

JPMorgan Chase & Co. reduced its stake in Climb Bio, Inc. (NASDAQ:CLYM - Free Report) by 89.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and...

Climb Bio, Inc. (NASDAQ:CLYM) Receives Average Recommendation of "Buy" from Brokerages

Shares of Climb Bio, Inc. (NASDAQ:CLYM - Get Free Report) have been assigned an average recommendation of "Buy" from the twelve analysts that are currently covering the stock, Marketbeat reports. One...

Oppenheimer Raises Climb Bio (NASDAQ:CLYM) Price Target to $18.00

Oppenheimer upped their price target on shares of Climb Bio from $10.00 to $18.00 and gave the stock an "outperform" rating in a research report on Tuesday...

Climb Bio (NASDAQ:CLYM) Upgraded to "Strong-Buy" at Mizuho

Mizuho raised Climb Bio to a "strong-buy" rating in a research report on Wednesday...

Climb Bio's (CLYM) "Buy" Rating Reaffirmed at BTIG Research

BTIG Research reissued a "buy" rating and issued a $8.00 price objective on shares of Climb Bio in a research report on Wednesday...

Climb Bio, Inc. operates as a clinical-stage biotechnology company. The firm develops therapeutics for patients with immune-mediated diseases. Its lead product candidate, budoprutug, is an anti-CD19 antibody designed for a broad range of B-cell mediated diseases. The company was founded by Andrew D. Levin and Valerie Morisset on October 18, 2018 and is headquartered in Wellesley Hills, MA.

Climb Bio Inc.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

CLYMClimb Bio Inc.

Fundamentals

Latest CLYM News